BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 348529)

  • 21. In vitro IgG synthesis by peripheral blood lymphocytes of multiple sclerosis patients and normal individuals. Effect of multiple sclerosis and non-multiple sclerosis brain antigens.
    Rastogi SC; Birkeboek NH
    Eur Neurol; 1983; 22(2):131-7. PubMed ID: 6840145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis].
    Totolian NA; Gotovchikov AA; Lapin SV; Maksimov IV; Kodzaeva AIu; Prakhova LN; Il'ves AG; Skoromets AP; Totolian AA; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):73-86. PubMed ID: 23235427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The severity of disease and intensity of the immune response in multiple sclerosis].
    Schädlich HJ; Felgenhauer K; Schifferdecker M
    Nervenarzt; 1984 Aug; 55(8):441-3. PubMed ID: 6483066
    [No Abstract]   [Full Text] [Related]  

  • 24. The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis.
    Tourtellotte WW; Walsh MJ; Baumhefner RW; Staugaitis SM; Shapshak P
    Ann N Y Acad Sci; 1984; 436():52-67. PubMed ID: 6398024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [State of measles immunity in mulitple sclerosis].
    Atanadze SN
    Vopr Virusol; 1978; (3):259-67. PubMed ID: 695518
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoglobulin G distribution in multiple sclerosis brain. An immunofluorescence study.
    Tavolato BF
    J Neurol Sci; 1975 Jan; 24(1):1-11. PubMed ID: 162936
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: HL-A antigens and hypersensitivity to brain tissue in multiple sclerosis.
    Finkelstein S; Walford RL; Myers LW; Ellison GW
    Lancet; 1974 Apr; 1(7860):736. PubMed ID: 4132456
    [No Abstract]   [Full Text] [Related]  

  • 28. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorescent cell tracing in multiple sclerosis brain tissue.
    Tourtellotte WW; Kokmen E; Tavolato B; Kruger PS
    Trans Am Neurol Assoc; 1971; 96():318-20. PubMed ID: 4945920
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory effect of lymphoblast formation by IgG Serum fraction of M.S. patients.
    Chinen A; Yokoyama MM
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):101-7. PubMed ID: 4282968
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological changes in multiple sclerosis.
    Bloom BR
    Nature; 1980 Sep; 287(5780):275-6. PubMed ID: 7421989
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluorescent protein tracing in multiple sclerosis brain tissue.
    Simpson JF; Tourtellotte WW; Kokmen E; Parker JA; Itabashi HH
    Arch Neurol; 1969 Apr; 20(4):373-7. PubMed ID: 4894357
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoglobulin G in multiple-sclerosis central nervous system: isolation and determination of its antigenic specificity.
    Glynn P; Newcombe J; Cuzner ML
    Biochem Soc Trans; 1980 Oct; 8(5):609. PubMed ID: 6161045
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoregulation in multiple sclerosis.
    Arnason BG; Antel JP; Reder AT
    Ann N Y Acad Sci; 1984; 436():133-9. PubMed ID: 6241817
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular immunity to encephalitogenic protein in multiple sclerosis. Correlations with other laboratory characteristics at different disease courses.
    Nilsson O; Thelin C
    Eur Neurol; 1977; 16(1-6):247-56. PubMed ID: 79488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-barr virus: environmental trigger of multiple sclerosis?
    Lünemann JD; Kamradt T; Martin R; Münz C
    J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenesis of multiple sclerosis. The Bradshaw lecture 1986.
    McDonald WI
    J R Coll Physicians Lond; 1987 Oct; 21(4):287-94. PubMed ID: 3316624
    [No Abstract]   [Full Text] [Related]  

  • 38. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.
    Rocklin RE; Sheremata WA; Feldman RG; Kies MW; David JR
    N Engl J Med; 1971 Apr; 284(15):803-8. PubMed ID: 4323673
    [No Abstract]   [Full Text] [Related]  

  • 39. On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis.
    Turner A; Cuzner ML; Davison AN; Rudge P
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):305-9. PubMed ID: 6966322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of cross-reactive antibodies to myelin and viral antigens in multiple sclerosis.
    Bernard CC; Townsend E
    Prog Clin Biol Res; 1984; 146():215-22. PubMed ID: 6201892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.